CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 4 Grant or award See Remark acquired 100,000 shares (grant or award)
- 4 Grant or award SVP, Chief Commercial Officer acquired 150,000 shares (grant or award)
- 4 Grant or award SVP, Operations acquired 110,000 shares (grant or award)
- 4 Grant or award Chief Innovation/Tech Officer acquired 100,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 447,000 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 150,000 shares (grant or award)
- 4 Grant or award SVP, Research & Development acquired 135,000 shares (grant or award)
- 4 Grant or award SVP, Chief Financial Officer acquired 140,000 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Bylaws or fiscal year change
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 16 of 35 · 690 filings